Cohen, S., Roy, J., Lachance, S., et al. (2020) Hematopoietic Stem Cell Transplantation Using Single UM171-Expanded Cord Blood: A Single-Arm, Phase 1-2 Safety and Feasibility Study. The Lancet Haematology, 7, e134-e145.
https://doi.org/10.1016/S2352-3026(19)30202-9

has been cited by the following article:

• TITLE: Isolation and Ex Vivo Expansion of Human Hematopoietic Stem Cells Derived from Umbilical Cord Blood

  AUTHORS: Mao Pang, Shiqian Han, Meng Ren, Dongwei Guan, Tianying Kuang, Shuixia Liu, Yesong Liu, Jieping Chen, Fengchao Wang, Chunmeng Shi, Zhijia Ye

  KEYWORDS: Hematopoietic Stem Cells, Isolation, Ex Vivo Expansion

  JOURNAL NAME: Stem Cell Discovery, Vol.11 No.1, January 30, 2021

  ABSTRACT: Umbilical cord blood (UCB) is a current major source of hematopoietic stem cells (HSCs) for cell transplantation therapy. Cell transplantation with HSCs derived from UCB is advantageous over transplantation with HSCs from adult tissues. However, the low number of HSC derived from a single unit of UCB limits its application. Thus, ex vivo expansion is a good option to create more UCB HSCs for clinical application. The strategies for HSC expansion in vitro focus on mimicking the composition and structure of HSC natural niche by enhancing self-renewal and inhibiting lineage differentiation of HSCs. In the past decade, the mechanisms of the interaction between HSC and the natural niche have been deeply investigated. This great progress in basic research has led to advancements in UCB HSC ex vivo expansion. In addition, the biological characteristics of the originally isolated UCB HSCs correlate with outcome of subsequent ex vivo expansion. In this paper, we summarize the late progress achieved in isolation and ex vivo expansion of UCB HSCs. Importantly, we attempt to provide an impact and practicable procedure to expand UCB HSC in vitro from isolation of original HSCs to identification of expanded HSCs.